医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

China and India to Lead Global Economic Recovery

2020年12月10日 PM04:02
このエントリーをはてなブックマークに追加


 

VILNIUS, Lithuania

Global real GDP growth will reach 5.1% in 2021 with developing and advanced economies at 6.1% and 3.8% respectively, according to global market research company Euromonitor International.

Findings from Euromonitor’s Global Recovery Tracker suggest that amongst the top ten largest economies, China and India will recover the fastest, while the UK and Brazil will take the longest.

India is leading the world’s economic recovery with a GDP growth set to reach 9% in 2021, a strong performance led by a 12.5% forecast increase in private consumption during the festive season at the end of this year. In second place, China’s GDP growth is forecast at 7.5% for 2021. With the country’s industrial and services sectors having already recovered by October 2020, its private and consumer sectors are following suit, signalling an acceleration in recovery.

In the UK, the situation between COVID-19 and Brexit causes uncertainty about the future and gives an additional shock to the economy. Giedrius Stalenis, economist at Euromonitor International states, “Unsuccessful Brexit negotiations would stagnate economic growth for the UK. However, if companies prepare better for a No-Deal Brexit, the UK economy could grow around 4% by 2021.”

In Brazil, while the energy and transportation sectors are still underperforming, the manufacturing and production sectors are showing signs of partial economic recovery, forecasting a 3.2% GDP growth in 2021, one of the lowest in the world. The increase in an ageing population is another contributing factor to a comparatively slower recovery rate in advanced economies, such as Japan, Italy and France.

To find out more, watch Euromonitor’s webinar ‘Global Economy in 2021: Outlook for Recovery and Potential Risks’.

About Euromonitor International

Euromonitor International is the world’s leading provider for global business intelligence, market analysis and consumer insights. From local to global and tactical to strategic, our research solutions support decisions on how, where and when to grow your business. Find the right report, database or custom solution to validate priorities, redirect assumptions and uncover new opportunities. With offices around the world, analysts in over 100 countries, the latest data science techniques and market research on every key trend and driver, we help you make sense of global markets.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201209005048/en/

CONTACT

For further information, please contact:

Justyna Petrovska

Communications Associate – Euromonitor International

Tel: +370 5 204 9121

justyna.petrovska@euromonitor.com

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表